Journal of Clinical and Experimental Ophthalmology
Open Access

Moss Fenberg

Publications

• Case Report
  Ranibizumab Monotherapy in Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment
  Author(s): Abumere Akinwale, Moss Fenberg, Vanessa Vasquez and Deeba HusainAbumere Akinwale, Moss Fenberg, Vanessa Vasquez and Deeba Husain
  
  Purpose: To evaluate the effect of ranibizumab monotherapy in patients with neovascular age related macular degeneration (AMD) associated with a pigment epithelial detachment (PED). Methods: A retrospective chart review of neovascular AMD with associated PED treated using initial three monthly doses of ranibizumab followed by as needed dosing. The response to treatment was assessed by evaluating changes in visual acuity and central macular thickness (CMT) by ocular coherence tomography. The total ranibizumab injections needed was also assessed. Results: A total of 14 eyes from 12 patients were included in this study. The average follow up period was 35 months (range 17 - 62 months). The mean logMAR visual acuity decreased from 0.596 (snellen ~ 20/80) to 1.018 (snellen ~20/200), however this was not statistically signific.. View More»
  

  Abstract PDF

Relevant Topics